Table 5

Clinical-pathological prognostic features of disease
False Negative mammograms (n = 20) vs. Incident (n = 65) P value OR
Mean age 60.8 + 1.1 vs. 59.7 + 0.6 N.S. 1.04 (0.93-1.15)
Mean size (cm) 1.17 + 0.16 vs. 1.27 + 0.09 N.S. 0.79 (0.34-1.86)
Lymph node positive 6.3% vs. 21.5% N.S. 0.24 (0.02-2.00)
Poorly differentiated tumors 50% vs. 40% N.S. 1.50 (0.50-4.49)
ER positive 95% vs. 89% N.S. 1.59 (0.17-14.4)
PR positive 85.7% vs. 78.2% N.S. 1.67 (0.32-8.52)
In situ carcinomas 6.3% vs. 11% N.S. 0.55 (0.06-4.84)
Apoptosis 42.9% vs. 66.7% N.S. 0.37 (0.06-2.15)
Bcl-2 84.6% vs. 81.3% N.S. 1.26 (0.23-6.75)
c-erb-B2 15% vs. 23.1% N.S. 0.41 (0.04-3.79)
Ki67 33.3% vs. 63% p < 0.05 0.29 (0.08-0.98)
Delay Diag- treat (>30 days) 37.9% vs. 35.4% N.S. 1.09 (0.33-3.59)

ER: estrogen receptor, PR: progesterone receptor.

Redondo et al.

Redondo et al. BMC Cancer 2012 12:604   doi:10.1186/1471-2407-12-604

Open Data